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Background: Immature platelet levels are easily measured, related to platelet RNA, and are a potentially useful biomarker of platelet activity. We 
investigated the reproducibility, effect of aspirin, and association of immature platelet levels with coronary artery disease (CAD).
methods: Following an overnight fast, 48 controls had 4 weekly blood collections. Aspirin 81mg was used between weeks 3 and 4. Subjects 
with CAD on aspirin monotherapy were included. Platelet count (PLT), immature platelet fraction (IPF) and immature platelet count (IPC) were 
investigated. Reproducibility was assessed by coefficient of variation (CV) and intraclass correlation coefficient (ICC). Paired comparison was 
measured using Wilcoxon signed-rank test and unpaired analysis using Wilcoxon rank-sum test.
results: Reproducibility in PLT (CV=8.0%, ICC=.88), IPF (CV=14%, ICC=.87) and IPC (CV=12%, ICC =.77) measurements were excellent. Aspirin had 
no significant effect on PLT, IPF or IPC. Subjects with CAD (vs controls) had similar PLT (214 [188-235] vs 208 x 103/µL [185-231], p=0.61) but 
significantly higher IPF (3.3% [2.2-4.9] vs 4.2% [3.1-5.4], p=0.03) and IPC (6.8 [5.1-9.7] vs 8.3 x 103/µL [6.8-11.3], p=0.03; Figure).
conclusions: Immature platelet levels are reproducible over time and significantly higher in subjects with CAD. Immature platelet levels may be a 
potentially useful biomarker reflecting platelet activity. Future studies correlating IPF and IPC with incident cardiovascular events are needed.
 
